Clinical Trials Logo

Clinical Trial Summary

To compare the relative efficacy and safety and of 5-FU Cream to the marketed formulation Efudex® (5-FU) Cream, and to demonstrate the superior efficacy of the two active formulations over that of the Vehicle Control Cream, in the treatment of actinic keratosis.


Clinical Trial Description

To compare the safety and efficacy profiles of 5-FU Cream with Efudex® (5-FU) Cream, and to demonstrate the superior efficacy of the two active formulations over that of the Vehicle Control Cream, in the treatment of actinic keratosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03727074
Study type Interventional
Source Sol-Gel Technologies, Ltd.
Contact
Status Completed
Phase Phase 3
Start date December 21, 2018
Completion date December 19, 2019

See also
  Status Clinical Trial Phase
Completed NCT01926496 - Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% Phase 4
Completed NCT03116698 - A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period Phase 2/Phase 3
Completed NCT02406014 - Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp Phase 4